Glenmark Pharmaceuticals

Glenmark Pharmaceuticals
Public company
Traded as BSE: 532296
NSE: GLENMARK)
Industry Pharmaceuticals
Founded 1977
Founders Gracias Saldanha
Headquarters Mumbai, Maharashtra[1], India
Key people
Glenn Saldanha, MD & CEO[2]
Products Medicines and Vaccines
Revenue 60.07 billion (US$880 million) (2009–2010)[3]
Number of employees
7,000[4]
Subsidiaries Glenmark Generics Ltd[5]
Website www.glenmarkpharma.com

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India.[6] It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans segments such as Dermatology, Internal Medicine, Paediatrics, Gynaecology, ENT and Diabetes.

It has four manufacturing facilities for formulations and additional three facilities for APIs. These manufacturing facilities are located in the states of Maharashtra, Goa, Himachal Pradesh and Gujarat in India.

It operates in 95 countries through its subsidiaries, Glenmark Pharmaceuticals USA, Glenmark Pharmaceuticals UK. Glenmark Pharmaceuticals SA.[7]

References

This article is issued from Wikipedia - version of the Friday, February 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.